{"component": "definition", "props": {"groups": [{"samples": [{"hash": "jXwHGxEvEUk", "uri": "https://pfmr.go.ke/wp-content/uploads/2020/11/PFM-ACT-2012.pdf", "label": "pfmr.go.ke", "score": 19.568901062, "published": false}, {"hash": "jeeh25Ax7Ba", "uri": "https://kenyalaw.org/kl/fileadmin/pdfdownloads/Cap_412A_Public_Finance_Management_Act.pdf", "label": "kenyalaw.org", "score": 17.1866607666, "published": false}, {"hash": "dwWj3gpNXnW", "uri": "https://igrtc.go.ke/views/img/Legislations/10/Public%20Finance%20Management%20Act.pdf", "label": "igrtc.go.ke", "score": 15.2897777557, "published": false}], "size": 20, "snippet_links": [{"key": "foreign-government", "type": "definition", "offset": [8, 26]}, {"key": "international-organisation", "type": "clause", "offset": [31, 57]}, {"key": "other-organisation", "type": "definition", "offset": [75, 93]}, {"key": "this-act", "type": "definition", "offset": [139, 147]}], "snippet": "means a foreign government, an international organisation of states or any other organisation prescribed by regulations for the purpose of this Act;", "hash": "e9c03c1a4c2b8686c6541d00b67956c4", "id": 1}, {"samples": [{"hash": "duqQeTocSGB", "uri": "/contracts/duqQeTocSGB#development-partner", "label": "Merger Agreement (Applied Molecular Transport Inc.)", "score": 34.7193717957, "published": true}, {"hash": "cxrj1OmUJ9r", "uri": "/contracts/cxrj1OmUJ9r#development-partner", "label": "Merger Agreement (Cyclo Therapeutics, Inc.)", "score": 34.7193717957, "published": true}, {"hash": "4afkpZqrI7N", "uri": "/contracts/4afkpZqrI7N#development-partner", "label": "Merger Agreement (Cyclo Therapeutics, Inc.)", "score": 34.7193717957, "published": true}], "size": 13, "snippet_links": [{"key": "any-person", "type": "clause", "offset": [6, 16]}, {"key": "pursuant-to-a", "type": "definition", "offset": [23, 36]}, {"key": "other-arrangement", "type": "clause", "offset": [49, 66]}, {"key": "the-company", "type": "definition", "offset": [72, 83]}, {"key": "right-to", "type": "definition", "offset": [177, 185]}, {"key": "regulatory-approval", "type": "clause", "offset": [210, 229]}, {"key": "company-product", "type": "clause", "offset": [276, 291]}], "snippet": "means any Person which pursuant to a Contract or other arrangement with the Company develops, co-develops, commercializes, co-commercializes or otherwise has a license or other right to research, develop, seek regulatory approval for, manufacture, supply, test, or import any Company Product, as applicable, or any of its Subsidiaries.", "hash": "604e0754f04e90c0d17181081e57467f", "id": 2}, {"samples": [{"hash": "77gk274qyH6", "uri": "/contracts/77gk274qyH6#development-partner", "label": "License Agreement (Diversa Corp)", "score": 21.0, "published": true}, {"hash": "4bIHXxPy2PH", "uri": "/contracts/4bIHXxPy2PH#development-partner", "label": "License Agreement (Xoma LTD /De/)", "score": 18.0, "published": true}, {"hash": "3WnyQWzTyQl", "uri": "/contracts/3WnyQWzTyQl#development-partner", "label": "License Agreement (Xoma LTD /De/)", "score": 18.0, "published": true}], "size": 8, "snippet_links": [{"key": "a-third-party", "type": "clause", "offset": [6, 19]}, {"key": "a-party", "type": "clause", "offset": [30, 37]}, {"key": "development-and-or-commercialization", "type": "definition", "offset": [70, 106]}, {"key": "economic-risk", "type": "clause", "offset": [139, 152]}, {"key": "on-behalf-of", "type": "clause", "offset": [246, 258]}, {"key": "applicable-party", "type": "definition", "offset": [263, 279]}], "snippet": "means a Third Party from whom a party either in-licenses a target for development and/or commercialization or with whom a party shares the economic risk of development or commercialization of a target or product being developed or commercialized on behalf of the applicable party.", "hash": "56399f9125c227e9688fd3e73b424a40", "id": 3}, {"samples": [{"hash": "6UDJvtwW3j2", "uri": "/contracts/6UDJvtwW3j2#development-partner", "label": "Strategic Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "dDlxHkyMzrB", "uri": "/contracts/dDlxHkyMzrB#development-partner", "label": "Strategic Collaboration Agreement (Palm Inc)", "score": 21.0, "published": true}, {"hash": "a6K3EYK7Dzm", "uri": "/contracts/a6K3EYK7Dzm#development-partner", "label": "Strategic Collaboration Agreement (Palmsource Inc)", "score": 21.0, "published": true}], "size": 6, "snippet_links": [{"key": "palmsource-licensee", "type": "definition", "offset": [8, 27]}, {"key": "joint-development-agreement", "type": "definition", "offset": [82, 109]}, {"key": "during-the-term-of-this-agreement", "type": "clause", "offset": [110, 143]}, {"key": "licensee-will", "type": "clause", "offset": [173, 186]}, {"key": "participate-in", "type": "definition", "offset": [187, 201]}, {"key": "development-program", "type": "definition", "offset": [207, 226]}, {"key": "new-versions", "type": "clause", "offset": [247, 259]}, {"key": "ps-os-software", "type": "definition", "offset": [267, 281]}, {"key": "ps-source-code", "type": "definition", "offset": [347, 361]}, {"key": "right-to-access", "type": "clause", "offset": [395, 410]}, {"key": "all-or-substantially-all", "type": "clause", "offset": [422, 446]}, {"key": "the-execution", "type": "clause", "offset": [473, 486]}, {"key": "partner-agreement", "type": "clause", "offset": [532, 549]}, {"key": "for-purposes-of-this-agreement", "type": "definition", "offset": [657, 687]}], "snippet": "means a PalmSource Licensee with whom PalmSource enters into a definitive written joint development agreement during the term of this Agreement, under which such PalmSource Licensee will participate in a co-development program with PalmSource for New Versions of the PS OS Software where such PalmSource Licensee develops material portions of the PS Source Code for the New Versions and has the right to access and modify all or substantially all of the PS Source Code for the execution of such co-development program (\u201cDevelopment Partner Agreement\u201d). A Development Partner and its Affiliates shall together be considered only a single Development Partner for purposes of this Agreement.", "hash": "053e981fa4059429d758212447655c20", "id": 4}, {"samples": [{"hash": "iNIA00xPSPn", "uri": "/contracts/iNIA00xPSPn#development-partner", "label": "Merger Agreement (Pyxis Oncology, Inc.)", "score": 34.390827179, "published": true}, {"hash": "52Xql813e0Z", "uri": "/contracts/52Xql813e0Z#development-partner", "label": "Merger Agreement (Apexigen, Inc.)", "score": 34.390827179, "published": true}, {"hash": "7IMClQhBqB", "uri": "https://ir.pyxisoncology.com/static-files/7842f80a-b6ec-4a1a-b927-1a16bed50cea", "label": "ir.pyxisoncology.com", "score": 19.2588233948, "published": false}], "size": 3, "snippet_links": [{"key": "any-person", "type": "clause", "offset": [6, 16]}, {"key": "pursuant-to-a", "type": "definition", "offset": [23, 36]}, {"key": "other-arrangement", "type": "clause", "offset": [49, 66]}, {"key": "the-company", "type": "definition", "offset": [72, 83]}, {"key": "right-to", "type": "definition", "offset": [204, 212]}, {"key": "regulatory-approval", "type": "clause", "offset": [237, 256]}, {"key": "company-product", "type": "clause", "offset": [303, 318]}], "snippet": "means any Person which pursuant to a Contract or other arrangement with the Company or any of its Subsidiaries develops, co-develops, commercializes, co-commercializes or otherwise has a license or other right to research, develop, seek regulatory approval for, manufacture, supply, test, or import any Company Product, as applicable, or any of its Subsidiaries.", "hash": "32e271564425c1a9125d2581fbf05559", "id": 5}, {"samples": [{"hash": "55z44nBcxsi", "uri": "https://www.ftc.gov/sites/default/files/documents/cases/2010/04/100427transopticaldo.pdf", "label": "www.ftc.gov", "score": 5.1806979179, "published": false}, {"hash": "iBjyqY1d3S6", "uri": "https://appliedantitrust.com/20_exclusive_contracts/exclusive_cases/transitions_optical/transitions_ftc_do_final4_27_2010.pdf", "label": "appliedantitrust.com", "score": 5.1587953568, "published": false}, {"hash": "d0PjGV29VzD", "uri": "https://appliedantitrust.com/20_exclusive_contracts/exclusive_cases/transitions_optical/transitions_ftc_po3_3_2010.pdf", "label": "appliedantitrust.com", "score": 5.0835046768, "published": false}], "size": 3, "snippet_links": [{"key": "direct-customer", "type": "definition", "offset": [10, 25]}, {"key": "terms-of", "type": "definition", "offset": [92, 100]}, {"key": "development-of-a", "type": "clause", "offset": [160, 176]}], "snippet": "means any Direct Customer that, together with Respondent, invests substantial resources, in terms of time, money and/or technical know-how, in the research and development of a new and innovative Photochromic Product.", "hash": "52ef216a9154ef59f24daf93f9a891f0", "id": 6}, {"samples": [{"hash": "eV585P4oeeN", "uri": "/contracts/eV585P4oeeN#development-partner", "label": "Collaboration Agreement (Receptos, Inc.)", "score": 24.2881584167, "published": true}, {"hash": "2BjuBpAfMGG", "uri": "/contracts/2BjuBpAfMGG#development-partner", "label": "Collaboration Agreement (Receptos, Inc.)", "score": 24.2553043365, "published": true}, {"hash": "id2SSWDOKXS", "uri": "/contracts/id2SSWDOKXS#development-partner", "label": "Collaboration Agreement (Receptos, Inc.)", "score": 24.1184120178, "published": true}], "size": 3, "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "a-party", "type": "clause", "offset": [23, 30]}, {"key": "third-party-partner", "type": "definition", "offset": [34, 53]}, {"key": "such-party", "type": "clause", "offset": [57, 67]}, {"key": "engaged-in", "type": "definition", "offset": [68, 78]}, {"key": "bona-fide", "type": "definition", "offset": [81, 90]}, {"key": "drug-development", "type": "clause", "offset": [91, 107]}, {"key": "the-target", "type": "clause", "offset": [146, 156]}], "snippet": "means, with respect to a Party, a Third Party partner of such Party engaged in a bona fide drug development arrangement with such Party involving the Target.", "hash": "fa66dfac26a70f094d42046312a46657", "id": 7}, {"samples": [{"hash": "fgl7l0E71b6", "uri": "https://static.pmg.org.za/african-renaissance-and-international-cooperation-fund-act-2000-act-no-51-of-2000-publication-of-the-arf-amendment-bill-for-public-comment_20230825-GGN-49189-03819-2-14.pdf", "label": "static.pmg.org.za", "score": 19.6008682251, "published": false}, {"hash": "hjTmHYsCpjL", "uri": "https://static.pmg.org.za/231129_ARF_amendment_Bill.pdf", "label": "static.pmg.org.za", "score": 18.3913040161, "published": false}, {"hash": "dwRiYmONNnh", "uri": "https://www.gov.za/sites/default/files/gcis_document/202308/49189gon3819.pdf", "label": "www.gov.za", "score": 18.2752609253, "published": false}], "size": 3, "snippet_links": [{"key": "not-limited", "type": "clause", "offset": [38, 49]}], "snippet": "means an entity that includes, but is not limited to, organs of", "hash": "b5a9ddf352e1fd4d7261bf9f44860798", "id": 8}, {"samples": [{"hash": "jtqQzed19TU", "uri": "/contracts/jtqQzed19TU#development-partner", "label": "Exclusive License Agreement (Quatrx Pharmaceuticals Co)", "score": 18.0, "published": true}, {"hash": "dUKmhGt8SYb", "uri": "/contracts/dUKmhGt8SYb#development-partner", "label": "Exclusive License Agreement (Quatrx Pharmaceuticals Co)", "score": 18.0, "published": true}], "size": 3, "snippet_links": [{"key": "person-or-entity", "type": "definition", "offset": [10, 26]}, {"key": "agreement-or", "type": "definition", "offset": [64, 76]}, {"key": "the-licensee", "type": "clause", "offset": [94, 106]}, {"key": "development-of-licensed-products", "type": "clause", "offset": [173, 205]}], "snippet": "means any person or entity other than a Sublicensee that has an agreement or arrangement with the Licensee, its Affiliates or any Sublicensee for the conduct of research or development of Licensed Products.", "hash": "0b8811415b1e46054f6af405cc1352cc", "id": 9}, {"samples": [{"hash": "ge3Aupiau5p", "uri": "/contracts/ge3Aupiau5p#development-partner", "label": "Non Exclusive License Agreement (Biotime Inc)", "score": 24.8631076813, "published": true}, {"hash": "2X2va4TPV9l", "uri": "/contracts/2X2va4TPV9l#development-partner", "label": "Non Exclusive License Agreement (Asterias Biotherapeutics, Inc.)", "score": 24.8631076813, "published": true}], "size": 3, "snippet_links": [{"key": "a-third-party", "type": "clause", "offset": [6, 19]}, {"key": "written-agreement", "type": "definition", "offset": [54, 71]}, {"key": "pursuant-to", "type": "clause", "offset": [72, 83]}, {"key": "to-the-extent", "type": "clause", "offset": [95, 108]}, {"key": "commercialization-of-products", "type": "clause", "offset": [168, 197]}, {"key": "by-licensee", "type": "clause", "offset": [232, 243]}], "snippet": "means a third party with which Licensee enters into a written agreement pursuant to and solely to the extent permitted by Section 2C for the further development and/or commercialization of Products initially substantially developed by Licensee.", "hash": "85622da36c04efcb0d185299040540d5", "id": 10}], "next_curs": "CmASWmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIcZGV2ZWxvcG1lbnQtcGFydG5lciMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"size": 99, "title": "Development Partner", "snippet": "means a foreign government, an international organisation of states or any other organisation prescribed by regulations for the purpose of this Act;", "id": "development-partner", "examples": ["Licensee will not receive from any <strong>Development Partner</strong> any payments or any non-cash consideration in exchange for the grant of a sublicense hereunder that is not fully accounted for under this Section 2C and Section 4C below.", "For sake of clarity, no right or license may be extended to a <strong>Development Partner</strong> to research, develop and/or commercialize any Product that was not initially substantially developed by Licensee, an Affiliate or Geron.", "WARF shall have the right to disapprove of a commercial sublicense with a <strong>Development Partner</strong> only if it reasonably believes that Licensee, Affiliates, or Geron have not previously invested at least [***] dollars in the development of the Product that is the subject of such sublicense, or that the rights extended under such sublicense are not reasonably necessary for the development or commercialization of the licensed Product."], "related": [["lead-partner", "Lead Partner", "Lead Partner"], ["economic-development-project", "Economic development project", "Economic development project"], ["co-licensed-partner", "Co-licensed partner", "Co-licensed partner"], ["development-team", "Development Team", "Development Team"], ["development-project", "Development Project", "Development Project"]], "related_snippets": [], "updated": "2026-03-07T04:27:53+00:00"}, "json": true, "cursor": ""}}